Within this framework and prior to your Ketamine experience, you will have the option to receive a The Neurosequential Model of Therapeutics™ (NMT™) Assessment before and after your full round of Ketamine treatment. The Neurosequential Model of Therapeutics™ (NMT™) is a neuroscience-informed, developmentally-sensitive approach to clinical problem solving created by Dr. Bruce Perry. It is not a therapy, and it does not endorse a single therapeutic method or technique. Rather, it helps the clinical team select and sequence specific therapeutic, educational and enrichment activities which are most likely to help address the client’s current challenges.

The NMT™ Clinical Practice Tools (AKA NMT™ Brain Map or NMT™ Metrics) help create a snapshot into the current functional organization of an individual’s ‘brain.’ This working model helps guide clinical treatment planning and allows ongoing re-evaluation of the treatment process. As the client changes, their needs will change. The NMT™ metric ensures the utilization of the most effective interventions, timed specifically for the client’s current developmental capabilities and needs, thereby optimizing the probability of success.